Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “XELOX”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Testing effectiveness (Phase 2)Study completedNCT00784446
What this trial is testing

First-line Therapy of Stage IV Colorectal Cancer

Who this might be right for
Stage IV Colorectal Cancer
University of Cologne 51
Large-scale testing (Phase 3)Study completedNCT05008783
What this trial is testing

AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 610
Not applicableStudy completedNCT06818097
What this trial is testing

Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC

Who this might be right for
Advanced HCCSystemic TherapyChemotherapy+3 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 68
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Testing effectiveness (Phase 2)Study completedNCT03564912
What this trial is testing

Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRC

Who this might be right for
Colorectal Cancer
Zhejiang University 160
Testing effectiveness (Phase 2)UnknownNCT04098796
What this trial is testing

PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaAFP
China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT04963088
What this trial is testing

Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT)

Who this might be right for
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University 65
Testing effectiveness (Phase 2)Study completedNCT01396707
What this trial is testing

Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX

Who this might be right for
Metastatic or Recurrent Gastric AdenocarcinomaHer-2 Positive Gastric Cancer
Asan Medical Center 55
Testing effectiveness (Phase 2)Study completedNCT04425564
What this trial is testing

Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients

Who this might be right for
Clinical ResponseToxicitySurvival
National Cancer Institute, Egypt 70
Post-approval studies (Phase 4)Study completedNCT01493713
What this trial is testing

Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer

Who this might be right for
Colorectal CancerHepatic Metastasis
Grupo Espanol Multidisciplinario del Cancer Digestivo 83
Testing effectiveness (Phase 2)Ended earlyNCT00101075
What this trial is testing

Title XELOX FOR SALIVARY GLAND CANCERS

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00421824
What this trial is testing

Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer

Who this might be right for
Rectal Neoplasms
Sanofi 108
Large-scale testing (Phase 3)Ended earlyNCT01748851
What this trial is testing

XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Carcinoma Stage IV
Dong-A University Hospital 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381777
What this trial is testing

XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Gruppo Oncologico Italiano di Ricerca Clinica 270
Large-scale testing (Phase 3)Looking for participantsNCT04787354
What this trial is testing

Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)

Who this might be right for
Gastric Cancer
Hallym University Medical Center 976
Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Testing effectiveness (Phase 2)Study completedNCT02015169
What this trial is testing

Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis

Who this might be right for
HER2-positive Gastric Cancer Patients With Liver Metastasis
Samsung Medical Center 32
Testing effectiveness (Phase 2)UnknownNCT04008511
What this trial is testing

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
China Medical University, China 54
Large-scale testing (Phase 3)Study completedNCT00399035
What this trial is testing

Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AstraZeneca 1,254
Testing effectiveness (Phase 2)UnknownNCT00496704
What this trial is testing

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

Who this might be right for
Colorectal Cancer
Yonsei University 56
Load More Results